Fed. Circ. Upholds Endo's Opioid Patent Win Against Generics
The Federal Circuit on Wednesday found that two opioid patents owned by Endo Pharmaceuticals Inc. are valid and had been infringed by the generic versions of the painkiller, affirming in full...To view the full article, register now.
Already a subscriber? Click here to view full article